JP2832979B2
(ja)
*
|
1988-02-15 |
1998-12-09 |
武田薬品工業株式会社 |
不飽和カルボン酸アミド誘導体
|
HU207310B
(en)
*
|
1988-12-02 |
1993-03-29 |
Pfizer |
Process for producing aryl-piperidine derivatives
|
JP2777159B2
(ja)
|
1988-12-22 |
1998-07-16 |
エーザイ株式会社 |
環状アミン誘導体を含有する医薬
|
JP2969359B2
(ja)
*
|
1989-01-13 |
1999-11-02 |
武田薬品工業株式会社 |
環状アミン化合物
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
JP2931986B2
(ja)
*
|
1989-02-17 |
1999-08-09 |
武田薬品工業株式会社 |
アラルキルアミン誘導体
|
US5250528A
(en)
*
|
1989-08-02 |
1993-10-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminopiperazine derivatives
|
US5109002A
(en)
*
|
1989-09-08 |
1992-04-28 |
Du Pont Merck Pharmaceutical Company |
Antipsychotic 1-cycloalkylpiperidines
|
WO1991006297A1
(en)
*
|
1989-10-27 |
1991-05-16 |
The Du Pont Merck Pharmaceutical Company |
(n-phthalimidoalkyl) piperidines
|
US5356906A
(en)
*
|
1989-10-27 |
1994-10-18 |
The Du Pont Merck Pharmaceutical Company |
(N-phthalimidoalkyl) piperidines useful as treatments for psychosis
|
HUT55358A
(en)
*
|
1989-10-30 |
1991-05-28 |
Syntex Inc |
Process for producing benzylpyrrolidine derivatives with dopamin antagonist effect and pharmaceutical compositions comprising such compounds
|
US5206240A
(en)
*
|
1989-12-08 |
1993-04-27 |
Merck & Co., Inc. |
Nitrogen-containing spirocycles
|
US5215989A
(en)
*
|
1989-12-08 |
1993-06-01 |
Merck & Co., Inc. |
Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
|
US5032604A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
US5112824A
(en)
*
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
US5032598A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
|
CA2071897A1
(en)
*
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
US5428043A
(en)
*
|
1990-02-08 |
1995-06-27 |
Pfizer Inc. |
Tricyclic-cyclic amines as novel cholinesterase inhibitors
|
US5272157A
(en)
*
|
1990-03-07 |
1993-12-21 |
Synthelabo |
Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
|
FR2659323B1
(fr)
*
|
1990-03-07 |
1992-06-12 |
Synthelabo |
Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
|
US5116846A
(en)
*
|
1990-03-28 |
1992-05-26 |
Du Pont Merck Pharmaceutical Company |
N-aralkyl piperidine derivatives as psychotropic drugs
|
US5173209A
(en)
*
|
1990-05-10 |
1992-12-22 |
Cyprus Foote Mineral Company |
Stable lithium cycloalkylimides
|
JP2869512B2
(ja)
*
|
1990-06-01 |
1999-03-10 |
メレルダウファーマスーティカルズ インコーポレイテッド |
(+)―α―(2,3―ジメトキシフェニル)―1―[2―(4―フルオロフェニル)エチル]―4―ピペリジンメタノール
|
US6004980A
(en)
*
|
1990-06-01 |
1999-12-21 |
Merrell Pharmaceuticals, Inc. |
(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
JP2807577B2
(ja)
*
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
DE69123090D1
(de)
*
|
1990-07-06 |
1996-12-19 |
Yoshitomi Pharmaceutical |
Kondensierte Thiophenverbindungen und deren Verwendung
|
FR2664592B1
(fr)
*
|
1990-07-10 |
1994-09-02 |
Adir |
Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
TW199153B
(fi)
*
|
1990-08-07 |
1993-02-01 |
Dtsuka Seiyaku Kk |
|
US5190951A
(en)
*
|
1990-10-19 |
1993-03-02 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
US5240934A
(en)
*
|
1990-10-19 |
1993-08-31 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
TW197435B
(fi)
*
|
1990-11-22 |
1993-01-01 |
Takeda Pharm Industry Co Ltd |
|
DE4104870A1
(de)
*
|
1991-02-17 |
1992-08-27 |
Bayer Ag |
Verwendung von 3,(4)-substituierten pyrrolidinen als katalysatoren fuer das polyisocyanatpolyadditionsverfahren, verfahren zu ihrer herstellung sowie verfahren zur herstellung von polyurethan(harnstoff)en
|
US5162341A
(en)
*
|
1991-02-22 |
1992-11-10 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of amphetamine abuse
|
CZ289756B6
(cs)
*
|
1991-03-28 |
2002-04-17 |
Eisai Co., Ltd. |
Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů
|
US5750542A
(en)
*
|
1993-09-28 |
1998-05-12 |
Pfizer |
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
|
FR2676226B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
FR2676225B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
CA2067475C
(en)
*
|
1991-05-08 |
2000-10-10 |
Yasuo Oshiro |
Carbostyril derivatives and their use
|
US5556857A
(en)
*
|
1991-05-08 |
1996-09-17 |
Otsuka Pharmaceutical Co., Ltd. |
Disturbance-of-consciousness improving agent
|
FR2677019B1
(fr)
*
|
1991-05-27 |
1994-11-25 |
Pf Medicament |
Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
|
US5106856A
(en)
*
|
1991-06-07 |
1992-04-21 |
Hoechst-Roussel Pharmaceuticals Inc. |
[(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-ones and related compounds
|
EP0535496A1
(en)
|
1991-09-25 |
1993-04-07 |
Hoechst-Roussel Pharmaceuticals Incorporated |
(1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
|
TW263504B
(fi)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
SE9103752D0
(sv)
*
|
1991-12-18 |
1991-12-18 |
Astra Ab |
New compounds
|
US5462934A
(en)
*
|
1992-03-09 |
1995-10-31 |
Takeda Chemical Industries |
Condensed heterocyclic ketone derivatives and their use
|
EP0567090B1
(en)
*
|
1992-04-24 |
2000-07-26 |
Takeda Chemical Industries, Ltd. |
Benzoxazepine derivatives as cholinesterase inhibitors
|
WO1994007890A1
(en)
*
|
1992-10-05 |
1994-04-14 |
Ube Industries, Ltd. |
Pyrimidine compound
|
US5914328A
(en)
*
|
1992-10-09 |
1999-06-22 |
Abbott Laboratories |
Heterocyclic ether compounds useful in controlling neurotransmitter release
|
US5948793A
(en)
*
|
1992-10-09 |
1999-09-07 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
|
TW248556B
(fi)
*
|
1993-01-18 |
1995-06-01 |
Takeda Pharm Industry Co |
|
CA2136999C
(en)
*
|
1993-04-07 |
2004-05-11 |
Takafumi Fujioka |
Peripheral vasodilating agent containing piperidine derivative as active ingredient
|
US5459151A
(en)
*
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
US6087346A
(en)
*
|
1993-06-23 |
2000-07-11 |
Cambridge Neuroscience, Inc. |
Sigma receptor ligands and the use thereof
|
DK0637586T3
(da)
*
|
1993-08-05 |
1999-12-06 |
Hoechst Marion Roussel Inc |
2-(Piperidin-4-yl, pyridin-4-yl og tetrahydropyridin-4-yl)-benzofuran-7-carbamatderivater, deres fremstilling og anvendelse
|
GB9319534D0
(en)
*
|
1993-09-22 |
1993-11-10 |
Boots Co Plc |
Therapeutic agents
|
ES2108484T3
(es)
*
|
1993-11-30 |
1997-12-16 |
Pfizer |
Procedimiento para la preparacion de una tetralona asimetrica.
|
DE4439822A1
(de)
*
|
1994-11-08 |
1996-08-29 |
Bayer Ag |
Verfahren zur Herstellung von Benzyl-piperidylmethyl-indanonen
|
US5658909A
(en)
*
|
1994-11-17 |
1997-08-19 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
|
US6214994B1
(en)
|
1997-04-21 |
2001-04-10 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1′-yl propanones
|
US5859295A
(en)
*
|
1994-12-05 |
1999-01-12 |
University Of Kentucky Research Foundation |
Canavanine analogs and their use as chemotherapeutic agents
|
WO1996022280A1
(de)
*
|
1995-01-18 |
1996-07-25 |
Bayer Aktiengesellschaft |
N-substituierte-1-acylaminoalkyl piperidine zur behandlung von cerebralen störungen und depressionen
|
US5889006A
(en)
*
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
IL117149A0
(en)
*
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
US5703239A
(en)
*
|
1995-06-02 |
1997-12-30 |
Bristol-Myers Squibb Company |
Indanylpiperidines as melatonergic agents
|
US20100210590A1
(en)
*
|
1995-09-27 |
2010-08-19 |
Northwestern University |
Compositions and treatments for seizure-related disorders
|
EP0883607A1
(en)
*
|
1995-12-15 |
1998-12-16 |
Pfizer Inc. |
Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
|
US6025355A
(en)
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US5629325A
(en)
*
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
WO1997046526A1
(en)
*
|
1996-06-07 |
1997-12-11 |
Eisai Co., Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
|
SK285312B6
(sk)
*
|
1996-06-07 |
2006-10-05 |
Eisai Co., Ltd. |
Polymorf (III) donepezil hydrochloridu, spôsob jeho výroby a terapeutický prostriedok s jeho obsahom
|
TW513409B
(en)
*
|
1996-06-07 |
2002-12-11 |
Eisai Co Ltd |
Polymorphs of donepezil hydrochloride
|
US5935958A
(en)
*
|
1996-07-01 |
1999-08-10 |
Schering Corporation |
Muscarinic antagonists
|
FR2750991A1
(fr)
*
|
1996-07-12 |
1998-01-16 |
Pf Medicament |
Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
US6756389B2
(en)
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US5977138A
(en)
*
|
1996-08-15 |
1999-11-02 |
Schering Corporation |
Ether muscarinic antagonists
|
EP0934932A4
(en)
*
|
1996-08-22 |
2002-06-26 |
Meiji Seika Kaisha |
CHINOLINE DERIVATIVES AND PSYCHOTROPES MEDIUM
|
FR2752732B1
(fr)
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
US6133253A
(en)
*
|
1996-12-10 |
2000-10-17 |
Abbott Laboratories |
3-Pyridyl enantiomers and their use as analgesics
|
US5962535A
(en)
*
|
1997-01-17 |
1999-10-05 |
Takeda Chemical Industries, Ltd. |
Composition for alzheimer's disease
|
DE19707655A1
(de)
*
|
1997-02-26 |
1998-08-27 |
Hoechst Ag |
Kombinationspräparat zur Anwendung bei Demenz
|
CA2282654C
(en)
*
|
1997-03-03 |
2009-02-03 |
Eisai Co., Ltd. |
Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
|
WO1998056380A1
(en)
*
|
1997-06-11 |
1998-12-17 |
Alcon Laboratories, Inc. |
Method to reverse mydriasis
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
US5945421A
(en)
*
|
1997-08-11 |
1999-08-31 |
Warner-Lambert Company |
Dopamine D4 receptor antagonists
|
US6339087B1
(en)
|
1997-08-18 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Cyclic amine derivatives-CCR-3 receptor antagonists
|
IL125658A0
(en)
|
1997-08-18 |
1999-04-11 |
Hoffmann La Roche |
Ccr-3 receptor antagonists
|
CA2304505A1
(en)
*
|
1997-09-24 |
1999-04-01 |
Nova Molecular, Inc. |
Methods for increasing apoe levels for the treatment of neurodegenerative disease
|
DE69822218T2
(de)
|
1997-12-05 |
2005-02-03 |
Eisai Co., Ltd. |
Donepezil polykristalle und verfharen zu ihrer herstellung
|
CA2316360C
(en)
|
1998-01-16 |
2007-09-18 |
Eisai Co., Ltd. |
Process for production of donepezil derivative
|
US6713627B2
(en)
|
1998-03-13 |
2004-03-30 |
Aventis Pharmaceuticals Inc. |
Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
US6066636A
(en)
*
|
1998-06-30 |
2000-05-23 |
Schering Corporation |
Muscarinic antagonists
|
US6262081B1
(en)
|
1998-07-10 |
2001-07-17 |
Dupont Pharmaceuticals Company |
Composition for and method of treating neurological disorders
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
IL125809A
(en)
|
1998-08-17 |
2005-08-31 |
Finetech Lab Ltd |
Process and intermediates for production of donepezil and related compounds
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
US20020177593A1
(en)
|
1998-09-30 |
2002-11-28 |
Yuji Ishihara |
Agents and crystals for improving excretory potency of urinary bladder
|
EP1891954A3
(en)
*
|
1998-09-30 |
2009-01-14 |
Takeda Pharmaceutical Company Limited |
Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
|
JP3593037B2
(ja)
*
|
1998-11-20 |
2004-11-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピロリジン誘導体ccr−3受容体アンタゴニスト
|
CA2351631A1
(en)
|
1998-11-20 |
2000-06-02 |
F. Hoffmann-La Roche Ag |
Piperidine quaternary salts-ccr-3 receptor antagonists
|
AU2160900A
(en)
*
|
1998-12-11 |
2000-06-26 |
American Biogenetic Sciences, Inc. |
Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
|
US6277866B1
(en)
*
|
1999-03-03 |
2001-08-21 |
Eisai Co., Ltd. |
1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl]methylpiperidine
|
AU2825600A
(en)
|
1999-03-03 |
2000-09-21 |
Eisai Co. Ltd. |
Fluorides of 4-substituted piperidine derivatives
|
US6833370B1
(en)
|
1999-05-21 |
2004-12-21 |
Abbott Laboratories |
Heterocycle substituted aminoazacycles useful as central nervous system agents
|
GB9914486D0
(en)
|
1999-06-21 |
1999-08-18 |
Smithkline Beecham Plc |
Medicaments
|
GB9917406D0
(en)
|
1999-07-23 |
1999-09-22 |
Smithkline Beecham Plc |
Compounds
|
ES2284519T3
(es)
|
1999-09-01 |
2007-11-16 |
EISAI R&D MANAGEMENT CO., LTD. |
Derivados de piperidina 4-sustituida.
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
US20060183776A9
(en)
*
|
2000-03-03 |
2006-08-17 |
Eisai Co., Ltd. |
Liquid dosage formulations of donepezil
|
US20030153598A1
(en)
*
|
2000-07-25 |
2003-08-14 |
Raymond Pratt |
Methods for treating Parkinson's disease with cholinesterase inhibitors
|
EP1764101A1
(en)
*
|
2000-03-03 |
2007-03-21 |
Eisai R&D Management Co., Ltd. |
Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
|
ES2275670T3
(es)
|
2000-03-03 |
2007-06-16 |
EISAI R&D MANAGEMENT CO., LTD. |
Metodos novedosos utilizando inhibidores de colinesterasa.
|
CA2406383A1
(en)
*
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
A.beta.42 lowering agents
|
JP4150519B2
(ja)
*
|
2000-04-13 |
2008-09-17 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
1−ベンジルピリジニウム塩を含有してなるアセチルコリンエステラーゼ阻害剤
|
EP1300395B1
(en)
*
|
2000-06-21 |
2009-09-02 |
Eisai R&D Management Co., Ltd. |
4-substituted piperidine compound
|
WO2002002526A1
(fr)
*
|
2000-07-03 |
2002-01-10 |
Eisai Co., Ltd. |
Compositions pharmaceutiques servant a stabiliser la tension intraoculaire
|
CN1317276C
(zh)
*
|
2000-09-29 |
2007-05-23 |
中国科学院上海药物研究所 |
一类吲哚基哌啶类化合物及其制备方法和用途
|
AU2002224046A1
(en)
*
|
2000-12-07 |
2002-06-18 |
Fujisawa Pharmaceutical Co. Ltd. |
Nootropic effect enhancer
|
WO2002080928A1
(en)
*
|
2001-04-03 |
2002-10-17 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
DE60216275T2
(de)
*
|
2001-05-25 |
2007-06-21 |
Schering Corp. |
Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit
|
MXPA04001959A
(es)
*
|
2001-08-30 |
2005-02-17 |
Johnson & Johnson |
Tratamiento de la demencia y trastornos de la memoria con anticonvulsivantes e. inhibidores de acetilcolinesterasa.
|
WO2003024450A1
(en)
*
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating prion diseases
|
US20050226934A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
US20050249786A1
(en)
*
|
2001-09-28 |
2005-11-10 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
WO2003032914A2
(en)
*
|
2001-10-17 |
2003-04-24 |
Eisai Co., Ltd. |
Methods for treating substance abuse with cholinesterase inhibitors
|
GB0126378D0
(en)
*
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
WO2003061658A1
(fr)
*
|
2002-01-22 |
2003-07-31 |
Eisai Co., Ltd. |
Agent liant de récepteur sigma contenant un dérivé d'indanone
|
CA2475385A1
(en)
*
|
2002-02-07 |
2003-08-14 |
Eisai Co., Ltd. |
Hair growth promoting agent, percutaneously applied preparation, and hair growth promoting method
|
AU2003218180B2
(en)
*
|
2002-03-15 |
2008-03-20 |
Georgetown University |
Neuroprotective spirostenol pharmaceutical compositions
|
WO2003082820A1
(fr)
*
|
2002-03-29 |
2003-10-09 |
Eisai Co., Ltd. |
Derive de (1-indanone)-(1,2,3,6-tetrahydropyridine)
|
US20040033986A1
(en)
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
US7652039B2
(en)
|
2002-05-17 |
2010-01-26 |
Sequella, Inc. |
Methods of use and compositions for the diagnosis and treatment of infectious disease
|
IL165589A
(en)
|
2002-06-14 |
2012-04-30 |
Toyama Chemical Co Ltd |
Pharmaceutical preparation to improve brain function and use
|
IL150509A
(en)
*
|
2002-07-01 |
2007-07-04 |
Joseph Kaspi |
Pharmaceutical preparations containing donafazil hydrochloride
|
MXPA05000200A
(es)
*
|
2002-07-02 |
2005-06-06 |
Schering Corp |
Nuevos antagonistas del receptor neuropeptido y y5.
|
US7148354B2
(en)
*
|
2002-07-24 |
2006-12-12 |
Dr. Reddy's Laboratories Limited |
Process for preparation of donepezil
|
IL150982A
(en)
*
|
2002-07-30 |
2007-02-11 |
Ori Lerman |
Process for making Donafzil
|
GB0218326D0
(en)
*
|
2002-08-07 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
GEP20094759B
(en)
*
|
2002-10-24 |
2009-08-25 |
Merz Pharma Gmbh & Co Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
US20060014801A1
(en)
*
|
2002-11-22 |
2006-01-19 |
The Johns Hopkins University |
Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
|
JP2004189706A
(ja)
*
|
2002-12-13 |
2004-07-08 |
Eisai Co Ltd |
高度アルツハイマー型痴呆治療剤
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
|
US20080057491A1
(en)
*
|
2003-02-07 |
2008-03-06 |
Mckee Patrick A |
Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
|
US6953856B2
(en)
*
|
2003-02-12 |
2005-10-11 |
Usv, Limited |
Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
|
US6649765B1
(en)
|
2003-02-12 |
2003-11-18 |
Usv Limited, Bsd Marg. |
Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
|
US7186842B2
(en)
*
|
2003-02-12 |
2007-03-06 |
Usv, Ltd. |
Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
|
US20050288330A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Avinash Naidu |
Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
|
US7439365B2
(en)
*
|
2003-11-17 |
2008-10-21 |
Usv, Ltd. |
Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
|
CA2516618A1
(en)
*
|
2003-02-27 |
2004-09-10 |
Shirankai Kyoto University Faculty Of Medicine Alumni Association Inc. |
Pharmaceutical composition for treatment of drug dependence
|
US7521481B2
(en)
*
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
CN100422148C
(zh)
*
|
2003-02-27 |
2008-10-01 |
天津药物研究院 |
工业化生产盐酸多奈哌齐的工艺方法
|
US20060009433A1
(en)
*
|
2003-03-14 |
2006-01-12 |
Zhi-Xing Yao |
Neuroprotective spirostenol pharmaceutical compositions
|
US20070129549A1
(en)
*
|
2003-03-21 |
2007-06-07 |
Yatendra Kumar |
Stable lamotrigine pharmaceutical compositions and processes for their preparation
|
US7772399B2
(en)
*
|
2003-04-02 |
2010-08-10 |
Hetero Drugs Limited |
Process for amorphous form of donepezil hydrochloride
|
US20040229914A1
(en)
*
|
2003-04-02 |
2004-11-18 |
Dr. Reddy's Laboratories Limited |
Novel crystalline form-VI of donepezil hydrochloride and process for the preparation thereof
|
AU2003245029A1
(en)
|
2003-04-16 |
2004-11-04 |
Hetero Drugs Limited |
Novel crystalline forms of donepezil hydrochloride
|
EP1654230A1
(en)
*
|
2003-07-01 |
2006-05-10 |
Hetero Drugs Limited |
Preparation of intermediates for acetyl cholinesterase inhibitors
|
US20050042284A1
(en)
*
|
2003-07-11 |
2005-02-24 |
Myriad Genetics, Incorporated |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
RU2357734C2
(ru)
*
|
2003-07-25 |
2009-06-10 |
Ф.Хоффманн-Ля Рош Аг |
КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА mGluR2 И ИНГИБИТОРА ФЕРМЕНТА AChE ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И/ИЛИ ХРОНИЧЕСКИХ НЕВРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ
|
CN1280273C
(zh)
|
2003-11-05 |
2006-10-18 |
天津和美生物技术有限公司 |
合成多奈哌齐及其衍生物的方法
|
EP1689721B1
(en)
*
|
2003-11-26 |
2010-07-14 |
Pfizer Products Inc. |
Aminopyrazole derivatives as gsk-3 inhibitors
|
WO2005065645A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Donepezil formulations
|
CN1300112C
(zh)
*
|
2004-01-06 |
2007-02-14 |
浙江大学 |
N-苄基-4-哌啶基甲醛的合成方法
|
WO2005072713A2
(en)
|
2004-01-27 |
2005-08-11 |
The Feinstein Institute For Medical Research |
Cholinesterase inhibitors for treating inflammation
|
MY142362A
(en)
*
|
2004-01-29 |
2010-11-30 |
Otsuka Pharma Co Ltd |
Pharmaceutical composition for promoting angiogenesis
|
US20080312189A1
(en)
*
|
2004-03-05 |
2008-12-18 |
Eisai Co., Ltd. |
Cadasil Treatment with Cholinesterase Inhibitors
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
JP4696062B2
(ja)
*
|
2004-04-28 |
2011-06-08 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
1−ベンジル−4−[(5,6−ジメトキシ−1−インダノン)−2−イル]メチルピペリジンおよびその塩酸塩の製造法
|
CN1946906A
(zh)
*
|
2004-04-29 |
2007-04-11 |
吉斯通护岸系统股份有限公司 |
用于墙、护墙和类似物的饰面
|
AU2005244867A1
(en)
*
|
2004-05-14 |
2005-12-01 |
The Johns Hopkins University |
Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor
|
WO2006004201A1
(ja)
|
2004-07-01 |
2006-01-12 |
Eisai R & D Management Co., Ltd. |
神経再生促進剤
|
US20080114173A1
(en)
*
|
2004-07-30 |
2008-05-15 |
Mathad Vijayavitthal Thippanna |
Crystalline Form of Donepezil Hydrochloride
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
CA2618985A1
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
HUP0401850A3
(en)
*
|
2004-09-15 |
2008-03-28 |
Egis Gyogyszergyar Nyilvanosan |
Donepezil salts for producing pharmaceutical composition
|
WO2006036936A2
(en)
|
2004-09-27 |
2006-04-06 |
Bridge Pharma, Inc. |
The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
|
AU2005288521A1
(en)
*
|
2004-09-29 |
2006-04-06 |
Chemagis Ltd. |
Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
|
GB2419093A
(en)
*
|
2004-10-12 |
2006-04-19 |
Ernir Snorrason |
Acetylcholinesterase inhibitors for the treatment of skin
|
EP1807087A2
(en)
*
|
2004-10-12 |
2007-07-18 |
Ernir Snorrason |
Inhibitors of acetylcholinesterase for treating skin diseases
|
ATE523199T1
(de)
*
|
2004-11-02 |
2011-09-15 |
Univ Northwestern |
Pyridazinverbindungen und verfahren
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
ATE439347T1
(de)
*
|
2004-11-23 |
2009-08-15 |
Warner Lambert Co |
7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
|
US20060122226A1
(en)
|
2004-12-08 |
2006-06-08 |
Itai Adin |
Crystalline forms of Donepezil base
|
JP4980242B2
(ja)
*
|
2004-12-30 |
2012-07-18 |
ジュビラント・オルガノシス・リミテッド |
新規の中間体を介する1−ベンジル−4−[(5,6−ジメトキシ−1−インダノン−2−イル)メチル]ピペリジンまたはその塩の製造方法
|
JP5731094B2
(ja)
|
2005-02-11 |
2015-06-10 |
スティーブン・ウィルスStephen WILLS |
アセチルコリンエステラーゼ阻害剤による微小血管系疾患の治療
|
WO2006097341A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Synthon B.V. |
Process for making crystalline donepezil hydrochloride monohydrate
|
US20060270709A1
(en)
*
|
2005-04-04 |
2006-11-30 |
Eisai Co. Ltd. |
Dihydropyridine compounds and compositions for headaches
|
WO2006121560A2
(en)
*
|
2005-04-06 |
2006-11-16 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of cns disorders
|
US20080188510A1
(en)
*
|
2005-05-23 |
2008-08-07 |
Eisai R & D Management Co., Ltd. |
Novel methods using zonisamide
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
US20090171094A1
(en)
*
|
2005-07-15 |
2009-07-02 |
Kazuhide Ashizawa |
1-benzyl-4-[(5, 6-dimethoxy- 1- indanon)- 2- yl]-methyl piperidine p-toluenesulfonate or crystal thereof
|
CA2615063A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
KR20080027885A
(ko)
*
|
2005-07-25 |
2008-03-28 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
1-벤질-4-[(5,6-디메톡시-1-인다논)-2-일리덴]메틸피페리딘의 제조 방법
|
US20070026075A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Jutaro Shudo |
Gelled donepezil compositions and methods for making and using the same
|
CN100436416C
(zh)
*
|
2005-07-29 |
2008-11-26 |
西南合成制药股份有限公司 |
盐酸多奈哌齐合成工艺
|
GB0515803D0
(en)
*
|
2005-07-30 |
2005-09-07 |
Pliva Hrvatska D O O |
Intermediate compounds
|
WO2007043440A1
(ja)
|
2005-10-14 |
2007-04-19 |
Eisai R & D Management Co., Ltd. |
1-ベンジル-4-[(5,6-ジメトキシ-1-インダノン)-2-イル]メチルピペリジンまたはその塩酸塩の製造法
|
DE602006018503D1
(de)
*
|
2005-10-14 |
2011-01-05 |
Eisai R&D Man Co Ltd |
Verfahren zur herstellung von 1-benzyl-4-ä(5,6-dimethoxy-1indanon)-2-ylümethylpiperidin oder des hydrochlorids davon
|
BRPI0617852A2
(pt)
*
|
2005-10-25 |
2011-08-09 |
Shionogi & Co |
compostos derivados de aminodi-hidrotiazina assim como composições contendo os mesmos
|
JP2008280248A
(ja)
*
|
2005-11-02 |
2008-11-20 |
Eisai R & D Management Co Ltd |
アルツハイマー型痴呆症治療薬塩酸ドネペジルのプロドラッグ
|
AR057910A1
(es)
*
|
2005-11-18 |
2007-12-26 |
Synthon Bv |
Proceso para preparar donepezilo
|
HU227474B1
(en)
*
|
2005-12-20 |
2011-07-28 |
Richter Gedeon Nyrt |
Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
|
ES2354737T3
(es)
*
|
2006-01-04 |
2011-03-17 |
Cipla Limited |
Procedimiento y producto intermedio para la preparación de donepezylo.
|
US7994328B2
(en)
|
2006-02-16 |
2011-08-09 |
Aurobindo Pharma Ltd. |
Process for the preparation of donepezil hydrochloride
|
JPWO2007099828A1
(ja)
|
2006-02-23 |
2009-07-16 |
塩野義製薬株式会社 |
環式基で置換された含窒素複素環誘導体
|
WO2007108011A2
(en)
*
|
2006-03-20 |
2007-09-27 |
Ind-Swift Laboratories Limited |
Process for the preparation of highly pure donepezil
|
CA2650711A1
(en)
*
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
EP2026766A1
(en)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Tablet composition with a prolonged release of tamsulosin
|
US8933201B2
(en)
|
2006-06-07 |
2015-01-13 |
The Board Of Regents Of The University Of Oklahoma |
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
|
EP2046119A2
(en)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
PL2046833T3
(pl)
|
2006-07-14 |
2014-01-31 |
Ac Immune Sa |
Humanizowane przeciwciało przeciw amyloidowi beta
|
WO2008010235A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Torrent Pharmaceuticals Limited |
An improved process for the preparation of donepezil
|
US7592458B2
(en)
|
2006-07-21 |
2009-09-22 |
Wright George E |
Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
|
WO2008019431A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Brc Operations Pty Limited |
Method and compositions for simultaneously regulating memory and mood
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
KR20090087009A
(ko)
|
2006-10-27 |
2009-08-14 |
메디베이션 뉴롤로지 인코퍼레이티드 |
아이.에이. 다임본 및 도레페질을 사용하여 알츠하이머 병을 치료하기 위한 조합 요법
|
WO2008073452A1
(en)
*
|
2006-12-11 |
2008-06-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
|
JP2010520154A
(ja)
*
|
2007-03-05 |
2010-06-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経変性疾患のためのampaレセプターアンタゴニストおよびnmdaレセプターアンタゴニスト
|
KR20080092515A
(ko)
*
|
2007-04-12 |
2008-10-16 |
동화약품공업주식회사 |
도네페질 중간체의 제조방법
|
WO2008133273A1
(ja)
*
|
2007-04-24 |
2008-11-06 |
Shionogi & Co., Ltd. |
アルツハイマー症治療用医薬組成物
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
WO2008139984A1
(en)
*
|
2007-04-26 |
2008-11-20 |
Eisai R & D Management Co., Ltd. |
Cinnamide compounds for dementia
|
AU2008249745B2
(en)
*
|
2007-05-09 |
2012-01-12 |
Pfizer Inc. |
Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
|
PL2157973T3
(pl)
|
2007-05-22 |
2015-12-31 |
Otsuka Pharma Co Ltd |
Lek zawierający pochodną karbostyrylu i donepezil do leczenia choroby Alzheimera
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
KR20150055103A
(ko)
*
|
2007-06-12 |
2015-05-20 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
CA2690110A1
(en)
*
|
2007-07-13 |
2009-01-22 |
Eisai R&D Management Co., Ltd. |
Ampa receptor antagonists for neuropathic pain
|
DE102007037932A1
(de)
|
2007-08-11 |
2009-02-12 |
Alfred E. Tiefenbacher Gmbh & Co.Kg |
Donepezilhydrochlorid in amorpher Form enthaltende Tablette
|
US8304435B2
(en)
*
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
CN101397270B
(zh)
*
|
2007-09-28 |
2012-03-28 |
天津和美生物技术有限公司 |
多奈哌齐盐的多晶型物及其制备和应用
|
TWI432195B
(zh)
|
2007-10-03 |
2014-04-01 |
Kowa Co |
神經細胞死亡抑制劑
|
CA2701790A1
(en)
*
|
2007-10-05 |
2009-04-16 |
Ac Immune S.A. |
Use of humanized anti-beta-amyloid antibody in ocular diseases
|
US9403902B2
(en)
*
|
2007-10-05 |
2016-08-02 |
Ac Immune S.A. |
Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody
|
JP5566004B2
(ja)
|
2007-11-14 |
2014-08-06 |
株式会社Dnpファインケミカル宇都宮 |
アルコキシインダノン誘導体の製造方法
|
US8987458B2
(en)
*
|
2008-03-25 |
2015-03-24 |
Cipla Limited |
Process for the preparation of donepezil hydrochloride
|
US8461389B2
(en)
|
2008-04-18 |
2013-06-11 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
WO2009151098A1
(ja)
|
2008-06-13 |
2009-12-17 |
塩野義製薬株式会社 |
βセクレターゼ阻害作用を有する含硫黄複素環誘導体
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
EP2328582A4
(en)
*
|
2008-09-30 |
2012-02-22 |
Teikoku Pharma Usa Inc |
DERPEZIL COMPOSITIONS WITH EXTENDED TRANSDERMAL DELIVERY AND METHODS OF USE
|
EP2360155A4
(en)
*
|
2008-10-22 |
2012-06-20 |
Shionogi & Co |
2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
|
US20100105916A1
(en)
*
|
2008-10-29 |
2010-04-29 |
Sterling Biotech Limited |
Processes for Preparing Donepezil
|
CN102272120B
(zh)
*
|
2008-11-07 |
2013-12-25 |
H.隆德贝克有限公司 |
生物活性酰胺
|
WO2010077730A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Auspex Pharmaceutical, Inc |
Indanone inhibitors of acetylcholinesterase
|
US8247405B2
(en)
|
2008-12-10 |
2012-08-21 |
Conopco, Inc. |
Skin lightening compositions with acetylcholinesterase inhibitors
|
WO2010071216A1
(en)
|
2008-12-17 |
2010-06-24 |
Eisai R&D Management Co., Ltd. |
Polymorphic crystal of donepezil and process for producing the same
|
US8465770B2
(en)
*
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
EP2674150A1
(de)
|
2009-01-28 |
2013-12-18 |
Labtec GmbH |
Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
|
JP4666093B2
(ja)
*
|
2009-03-13 |
2011-04-06 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸エステルの製造法
|
CN102482304B
(zh)
*
|
2009-07-10 |
2014-09-03 |
优迈特株式会社 |
多氟烷基膦酸酯和其制备方法
|
WO2011055609A1
(ja)
*
|
2009-11-04 |
2011-05-12 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸塩乳化剤およびこれを有効成分とする離型剤
|
PT2513085T
(pt)
|
2009-11-18 |
2016-11-14 |
Suven Life Sciences Ltd |
Compostos bicíclicos como ligantes do recetor da acetilcolina nicotínico alfa4beta2
|
WO2011061591A1
(en)
|
2009-11-18 |
2011-05-26 |
Jubilant Life Sciences Limited |
Improved process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanone)-2-yl)methyl piperidine hydrochloride form-iii
|
RU2012129168A
(ru)
|
2009-12-11 |
2014-01-20 |
Сионоги Энд Ко. Лтд. |
Производные оксазина
|
AU2010337837B2
(en)
|
2009-12-29 |
2013-09-05 |
Suven Life Sciences Limited |
Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
BR112012019923A2
(pt)
|
2010-02-09 |
2016-08-09 |
Univ Johns Hopkins |
métodos e composições para melhorar a função cognitiva
|
WO2011127235A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
GR1007368B
(el)
|
2010-05-27 |
2011-08-02 |
Alapis Α.Β.Ε.Ε., |
Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια των συμπτωματων της ανοιας
|
WO2011151359A1
(en)
|
2010-06-02 |
2011-12-08 |
Noscira, S.A. |
Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
|
FR2962335B1
(fr)
|
2010-07-12 |
2013-01-18 |
Cll Pharma |
Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
|
JP6081356B2
(ja)
|
2010-07-30 |
2017-02-15 |
エーシー イミューン エス.エー. |
安全で機能的なヒト化抗βアミロイド抗体
|
TR201007109A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Tek birim dozaj formları.
|
TR201007110A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Sinerjik etki gösteren kombinasyonlar
|
WO2012038966A1
(en)
|
2010-09-22 |
2012-03-29 |
Tyche Industries Ltd. |
Process for the preparation of donepezil intermediate
|
US9018219B2
(en)
|
2010-10-29 |
2015-04-28 |
Shionogi & Co., Ltd. |
Fused aminodihydropyrimidine derivative
|
AU2011321427A1
(en)
|
2010-10-29 |
2013-05-02 |
Shionogi & Co., Ltd. |
Naphthyridine derivative
|
EP2640391B1
(en)
|
2010-11-15 |
2015-11-11 |
Agenebio, Inc. |
Pyridazine derivatives, compositions and methods for treating cognitive impairment
|
US8980924B2
(en)
|
2010-11-24 |
2015-03-17 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
JPWO2012147763A1
(ja)
|
2011-04-26 |
2014-07-28 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するbace1阻害剤
|
WO2012156192A1
(de)
|
2011-05-16 |
2012-11-22 |
Weitzer Holding Gmbh |
Boden- oder wandbelagsystem mit modular kombinierbaren verlegeeinheiten
|
EP2565186A1
(en)
|
2011-09-02 |
2013-03-06 |
Hybrigenics S.A. |
Selective and reversible inhibitors of ubiquitin specific protease 7
|
ES2727815T3
(es)
|
2012-04-14 |
2019-10-18 |
Intra Cellular Therapies Inc |
Tratamiento del TEPT y de trastornos del control de impulsos
|
CN103524515B
(zh)
*
|
2012-07-03 |
2016-07-06 |
浙江海正药业股份有限公司 |
具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
CN103787954B
(zh)
*
|
2012-10-26 |
2016-01-20 |
中国科学院上海药物研究所 |
一类氟取代的环状胺类化合物及其制备方法、药物组合物和用途
|
CA2891122C
(en)
|
2012-11-14 |
2021-07-20 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
JPWO2014076965A1
(ja)
*
|
2012-11-16 |
2017-01-05 |
学校法人北里研究所 |
抗原虫活性を示す1−インダン誘導体
|
EP2759536A1
(en)
*
|
2013-01-25 |
2014-07-30 |
INSA (Institut National des Sciences Appliquees) de Rouen |
Oxidisable pyridine derivatives, their preparation and use as anti-Alzheimer agents
|
EP2968220B1
(en)
|
2013-03-15 |
2021-05-05 |
Agenebio, Inc. |
Methods and compositions for improving cognitive function
|
WO2014144663A1
(en)
|
2013-03-15 |
2014-09-18 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
WO2014171434A1
(ja)
|
2013-04-19 |
2014-10-23 |
国立大学法人岡山大学 |
アミロイドβ蛋白質により誘発される認知障害の治療剤およびアルツハイマー病治療薬、ならびにこれらに関連する治療方法および病態解析方法
|
WO2015022418A1
(en)
|
2013-08-16 |
2015-02-19 |
Takeda Gmbh |
Treatment of cognitive impairment with pde4 inhibitor
|
US9359315B2
(en)
|
2013-09-10 |
2016-06-07 |
Arrien Pharmaceuticals Llc |
Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
|
WO2015095783A1
(en)
|
2013-12-20 |
2015-06-25 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
FR3018689B1
(fr)
*
|
2014-03-20 |
2017-04-28 |
Centre Hospitalier Univ De Clermont Ferrand |
Inhibiteurs de l'acetylcholinesterase d'action centrale pour la prevention et/ou le traitement des neuropathies chimio-induites et leurs symptomes, compositions, utilisations, methodes et trousse correspondantes.
|
CN105753768B
(zh)
*
|
2014-12-15 |
2020-11-27 |
北京恒瑞新霖科技有限公司 |
一种含单个氮杂环化合物的生产方法
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
TWI698436B
(zh)
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
|
EP3253759A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
EP3253765A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
EP3253738A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
CN107810002B
(zh)
|
2015-05-22 |
2021-01-05 |
艾吉因生物股份有限公司 |
左乙拉西坦的延时释放药物组合物
|
JP6987384B2
(ja)
|
2015-06-19 |
2021-12-22 |
エージンバイオ, インコーポレイテッド |
ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
|
US20180185298A1
(en)
|
2015-06-22 |
2018-07-05 |
Corium International, Inc. |
Transdermal Adhesive Composition Comprising A Poorly Soluble Therapeutic Agent
|
CN105367483B
(zh)
*
|
2015-11-20 |
2017-12-26 |
山东淄博新达制药有限公司 |
盐酸多奈哌齐的制备方法
|
KR20190015492A
(ko)
|
2016-06-08 |
2019-02-13 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
화학적 화합물
|
EP3474831A1
(en)
|
2016-06-23 |
2019-05-01 |
Corium International, Inc. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
WO2018016714A1
(ko)
|
2016-07-20 |
2018-01-25 |
주식회사 엔솔바이오사이언스 |
신규 펩타이드 및 그 용도
|
SG11201900712SA
(en)
|
2016-07-27 |
2019-02-27 |
Corium Int Inc |
Memantine transdermal delivery systems
|
CN109789106B
(zh)
|
2016-07-27 |
2023-06-27 |
考里安有限责任公司 |
碳酸氢钠原位转化驱动胺药物的透皮递送
|
KR102424270B1
(ko)
|
2016-07-27 |
2022-07-25 |
코리움, 인크. |
경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
CA3085342A1
(en)
|
2017-12-13 |
2019-06-20 |
Corium, Inc. |
Method for depot creation during transdermal drug delivery
|
WO2019126531A1
(en)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
BR112020026062B1
(pt)
|
2018-06-19 |
2023-04-04 |
Agenebio, Inc |
Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
|
BR112021024054A2
(pt)
|
2019-05-31 |
2022-01-11 |
Tecnimede Soc Tecnico Medicinal Sa |
Composições farmacêuticas de combinação de dose fixa de liberação imediata, seus métodos e usos.
|
JP7452810B2
(ja)
*
|
2019-06-17 |
2024-03-19 |
東和薬品株式会社 |
固定化触媒を用いたフロー反応によるドネペジルの製造方法
|
KR20220059300A
(ko)
*
|
2020-11-02 |
2022-05-10 |
주식회사 종근당 |
인덴 유도체 프로드럭의 산부가염 및 이의 제조방법
|
KR102451185B1
(ko)
|
2021-08-05 |
2022-10-07 |
환인제약 주식회사 |
도네페질 함유 지속방출형 미립구
|
WO2024039886A1
(en)
|
2022-08-19 |
2024-02-22 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|